FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: SigmaTron

Sort
E.g., 2013-05-23
E.g., 2013-05-23
Enter a comma separated list of user names.

Sangamo Biosciences Inc. (NASDAQ:SGMO) previously reported the publication of preclinical data demonstrating protection of nerve tissue and functional improvements in motor symptoms in a validated rat model of Parkinson's disease (PD) using Sangamo's zinc finger protein (ZFP) technology. As previously disclosed, the study was supported by funding from The Michael J.

ADVERTISE WITH US